IRIS
PAGNESI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.038
NA - Nord America 1.370
AS - Asia 1.043
Continente sconosciuto - Info sul continente non disponibili 346
SA - Sud America 97
AF - Africa 30
OC - Oceania 5
Totale 4.929
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.293
US - Stati Uniti d'America 1.257
IT - Italia 418
CN - Cina 308
SG - Singapore 295
BD - Bangladesh 172
HK - Hong Kong 108
FR - Francia 90
BR - Brasile 63
GB - Regno Unito 55
SE - Svezia 50
CA - Canada 46
VN - Vietnam 41
IN - India 40
DE - Germania 38
MX - Messico 22
NL - Olanda 20
PL - Polonia 18
ZA - Sudafrica 16
FI - Finlandia 15
JM - Giamaica 15
JP - Giappone 14
IQ - Iraq 12
ES - Italia 11
CR - Costa Rica 9
TR - Turchia 9
AR - Argentina 8
SA - Arabia Saudita 8
VE - Venezuela 8
AT - Austria 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EC - Ecuador 6
PH - Filippine 6
CH - Svizzera 5
HN - Honduras 5
AU - Australia 4
MY - Malesia 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
KW - Kuwait 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
UA - Ucraina 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ID - Indonesia 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
GH - Ghana 1
HR - Croazia 1
KR - Corea 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TW - Taiwan 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
VU - Vanuatu 1
Totale 4.583
Salva come PNG Salva come JPEG
Città #
Moscow 262
Council Bluffs 187
Ashburn 157
Singapore 146
Hong Kong 106
Milan 101
San Jose 99
New York 74
Lauterbourg 65
Beijing 63
Santa Clara 52
Orem 47
Los Angeles 42
Dallas 40
Rome 37
Shanghai 31
Boardman 20
Chennai 20
Naples 17
Brescia 15
Ho Chi Minh City 15
Warsaw 15
Hefei 14
Tokyo 14
Bologna 13
Phoenix 13
Denver 12
Lappeenranta 12
Munich 12
Manchester 11
Poplar 11
Brooklyn 10
Mexico City 10
Atlanta 9
Boston 9
Buffalo 9
Catania 9
London 9
Toronto 9
Chicago 8
Frankfurt am Main 8
Hanoi 8
Kingston 8
Lawrence 8
Montreal 8
Princeton 8
São Paulo 8
Turin 8
Amsterdam 7
Houston 7
Johannesburg 7
Nuremberg 7
Omaha 7
Querétaro 7
San José 7
Cagliari 6
Caracas 6
Mumbai 6
Pretoria 6
Florence 5
Las Vegas 5
Monza 5
Newark 5
Palermo 5
Philadelphia 5
San Francisco 5
Stockholm 5
Canton 4
Da Nang 4
Delhi 4
Erbil 4
Figino 4
Genoa 4
Ittigen 4
Miami 4
Pasadena 4
Perugia 4
Reggio Emilia 4
Tianjin 4
Verona 4
Washington 4
York 4
Ankara 3
Baghdad 3
Bari 3
Birmingham 3
Charlotte 3
Colliano 3
Frisco 3
Guanzate 3
Guayaquil 3
Kuwait City 3
Longview 3
Managua 3
Padua 3
Queens 3
Québec 3
Rockville 3
San Pedro Sula 3
San Salvador 3
Totale 2.096
Salva come PNG Salva come JPEG
Nome #
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 133
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 123
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 105
A novel scoring system and decisional algorithm to predict functional recovery after heart valve surgery 101
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 99
Integrated clinical role of echocardiography in patients with COVID-19 99
2024 update in heart failure 96
Heart and Lung Multimodality Imaging in COVID-19 96
Neutrophil to lymphocyte ratio: a new preoperative predictive index of postoperative atrial fibrillation 92
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 83
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 82
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 82
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 80
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis 77
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 76
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 71
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 68
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 64
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 63
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 63
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 58
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 57
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 53
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 52
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 51
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 49
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 47
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 47
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 47
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 47
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 46
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 46
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 45
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 44
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 41
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 40
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 40
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 38
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock 38
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 37
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 37
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 37
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 36
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 36
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 36
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 36
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 36
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 35
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 35
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 35
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 34
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 34
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 33
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 33
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 33
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 32
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 32
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 32
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 32
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 31
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 31
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 31
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 31
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 31
Obesity and inflammation in chronic and acute heart failure 31
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 29
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 29
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 29
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 29
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 28
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 28
Combined pre- and post-capillary pulmonary hypertension in left heart disease 28
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 28
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 28
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 28
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial 27
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 27
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 27
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 27
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 27
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 27
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 27
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 26
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 26
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 26
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 26
Heart failure: an update from the last years and a look at the near future 26
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 26
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 25
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 25
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 25
Prognostic role of mitral regurgitation in patients with advanced heart failure 24
Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry 24
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 24
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 24
Reply to the letter regarding the article ‘Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure’ 24
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 24
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 24
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 23
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 23
Totale 4.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 7 3 1 0 1 0 0 0 0
2022/202362 19 15 5 0 0 9 0 8 0 0 2 4
2023/202473 0 5 12 10 12 6 2 15 0 0 6 5
2024/2025230 13 11 2 6 10 31 52 31 15 17 16 26
2025/20263.777 85 45 17 113 169 480 382 334 1.385 353 206 208
2026/2027748 377 371 0 0 0 0 0 0 0 0 0 0
Totale 4.929